Yuichi Tasaka

512 total citations
22 papers, 403 citations indexed

About

Yuichi Tasaka is a scholar working on Pharmacology, Geriatrics and Gerontology and Toxicology. According to data from OpenAlex, Yuichi Tasaka has authored 22 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 10 papers in Geriatrics and Gerontology and 5 papers in Toxicology. Recurrent topics in Yuichi Tasaka's work include Pharmacy and Medical Practices (14 papers), Pharmaceutical Practices and Patient Outcomes (10 papers) and Pharmacovigilance and Adverse Drug Reactions (5 papers). Yuichi Tasaka is often cited by papers focused on Pharmacy and Medical Practices (14 papers), Pharmaceutical Practices and Patient Outcomes (10 papers) and Pharmacovigilance and Adverse Drug Reactions (5 papers). Yuichi Tasaka collaborates with scholars based in Japan, Italy and Indonesia. Yuichi Tasaka's co-authors include Akihiro Tanaka, Hiroaki Araki, Tomoaki Ishihara, Tohru Mizushima, Ken‐ichiro Tanaka, Mamoru Tanaka, Yutaka Mizushima, Takushi Namba, Tsutomu Ishihara and Keizo Sato and has published in prestigious journals such as PLoS ONE, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

Yuichi Tasaka

17 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuichi Tasaka Japan	10	85	77	62	61	46	22	403
Marilyn S. Campbell United States	13	54 0.6×	108 1.4×	15 0.2×	21 0.3×	38 0.8×	29	727
Nanyang Liu China	14	11 0.1×	205 2.7×	42 0.7×	29 0.5×	63 1.4×	32	778
Soo Kyoung Park South Korea	15	19 0.2×	152 2.0×	32 0.5×	50 0.8×	29 0.6×	79	661
Yuexi Wang United States	11	9 0.1×	131 1.7×	12 0.2×	19 0.3×	49 1.1×	46	386
Liping Zhu China	12	8 0.1×	125 1.6×	40 0.6×	35 0.6×	66 1.4×	33	521
Matthias Kröz Germany	11	15 0.2×	73 0.9×	12 0.2×	31 0.5×	24 0.5×	35	384
Haiyan Shi China	11	30 0.4×	87 1.1×	11 0.2×	17 0.3×	20 0.4×	30	285
Amilia Aminuddin Malaysia	16	6 0.1×	102 1.3×	53 0.9×	42 0.7×	30 0.7×	73	712
Tingting Sun China	11	10 0.1×	146 1.9×	21 0.3×	27 0.4×	9 0.2×	35	550
Loreana Sanches Silveira Brazil	17	7 0.1×	193 2.5×	10 0.2×	20 0.3×	20 0.4×	37	733

Countries citing papers authored by Yuichi Tasaka

Since Specialization

Citations

This map shows the geographic impact of Yuichi Tasaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Tasaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Tasaka more than expected).

Fields of papers citing papers by Yuichi Tasaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichi Tasaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Tasaka. The network helps show where Yuichi Tasaka may publish in the future.

Co-authorship network of co-authors of Yuichi Tasaka

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichi Tasaka. A scholar is included among the top collaborators of Yuichi Tasaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichi Tasaka. Yuichi Tasaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsuchiya, Masami, et al.. (2024). Trend analysis of pharmacist involvement in cancer care in Japan from 2015 to 2020: A nationwide survey study on hospital pharmacy practice. Journal of Oncology Pharmacy Practice. 31(5). 803–809.

Tasaka, Yuichi, et al.. (2024). Cross-Cancer Type Evaluation of Potential Interstitial Lung Disease Complications of Immune Checkpoint Inhibitors Using JADER. Biological and Pharmaceutical Bulletin. 47(7). 1296–1300. 2 indexed citations

Ushio, Soichiro, et al.. (2024). Behavioural and neurochemical alterations following acute inflammation induced by intraperitoneal and intratracheal injection with lipopolysaccharide in mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(3). 2867–2878.

Tasaka, Yuichi, et al.. (2024). Evaluation of hospital pharmacists’ activities using additional reimbursement for infection prevention as an indicator in small and medium-sized hospitals. Journal of Pharmaceutical Health Care and Sciences. 10(1). 6–6. 1 indexed citations

Matsubara, Hideki, et al.. (2024). Characteristics of CYP3A4-related potential drug-drug interactions in outpatients receiving prescriptions from multiple clinical departments. Journal of Pharmaceutical Health Care and Sciences. 10(1). 48–48.

Tasaka, Yuichi, Yoshihisa Kitamura, Kenichi Shimada, et al.. (2023). A Trial of Practical Training on Online Medication Instructions in Clinical Preparatory Education: Development of Human Resources to Provide New Forms of Medical Care after the COVID-19 Pandemic. YAKUGAKU ZASSHI. 143(12). 1047–1056.

Tsuchiya, Masami, et al.. (2022). Characteristics of hospitals that report adverse drug reactions: Results of a nationwide survey in Japan. Journal of Clinical Pharmacy and Therapeutics. 47(8). 1240–1248. 1 indexed citations

Takeuchi, Haruka, et al.. (2022). Characteristics of Drug-related Problems in Outpatients Based on Analyses of PreAVOID Reports by Community Pharmacists. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 48(5). 194–202.

Kikuchi, Daisuke, et al.. (2022). Actual status of patient information sharing among healthcare delivery facilities: a survey by the third subcommittee, committee on academic research, the Japanese society of hospital pharmacists. Journal of Pharmaceutical Health Care and Sciences. 8(1). 30–30. 2 indexed citations

10.

Matsubara, Hideki, et al.. (2021). Potential Drug-Drug Interactions among Three or More Drugs: A Retrospective Multi-center Study in Pharmacies in the Kojima Region, Okayama. YAKUGAKU ZASSHI. 141(7). 979–984. 3 indexed citations

11.

Tasaka, Yuichi, et al.. (2018). Potential drug-related problems detected by routine pharmaceutical interventions: safety and economic contributions made by hospital pharmacists in Japan. Journal of Pharmaceutical Health Care and Sciences. 4(1). 33–33. 33 indexed citations

12.

Tasaka, Yuichi, et al.. (2016). Economic contributions of pharmaceutical interventions by pharmacists: a retrospective report in Japan. Journal of Pharmaceutical Policy and Practice. 10(1). 2–2. 12 indexed citations

13.

Tasaka, Yuichi, et al.. (2016). Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan. International Journal of Clinical Pharmacy. 38(2). 321–329. 22 indexed citations

14.

Kawazoe, Hitoshi, Akiko Yano, Yuichi Tasaka, et al.. (2016). Evaluation of Clinical Outcomes of Pharmaceutical Interventions in Outpatient Chemotherapy and Estimation of Their Associated Economic Impact. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 42(4). 228–236. 6 indexed citations

15.

Tasaka, Yuichi, Takeshi Kiyoi, Mamoru Tanaka, et al.. (2015). Involvement of stimulation of α7 nicotinic acetylcholine receptors in the suppressive effect of tropisetron on dextran sulfate sodium-induced colitis in mice. Journal of Pharmacological Sciences. 127(3). 275–283. 24 indexed citations

16.

Tasaka, Yuichi, et al.. (2014). Estimation of the Economic Impact Associated with Pharmaceutical Interventions. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 40(4). 208–214. 21 indexed citations

17.

Asai, Yoshiyuki, et al.. (2009). Correction: A Model of Postural Control in Quiet Standing: Robust Compensation of Delay-Induced Instability Using Intermittent Activation of Feedback Control. PLoS ONE. 4(7). 59 indexed citations

18.

Tanaka, Ken‐ichiro, Tomoaki Ishihara, Arata Azuma, et al.. (2009). Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 298(3). L348–L360. 64 indexed citations

19.

Ishihara, Tomoaki, Ken‐ichiro Tanaka, Yuichi Tasaka, et al.. (2008). Therapeutic Effect of Lecithinized Superoxide Dismutase against Colitis. Journal of Pharmacology and Experimental Therapeutics. 328(1). 152–164. 81 indexed citations

20.

Tanaka, Ken‐ichiro, et al.. (2008). Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis. European Journal of Pharmacology. 603(1-3). 120–132. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact